drugset / Trial / NCT02315872

ACTH for Fatigue in Multiple Sclerosis Patients

NCT02315872 ↗

RandomizedParallel-groupTriple-blindTreatment

Summary

This is a study of Acthar gel (ACTH) in patients with relapsing multiple sclerosis who are experiencing chronic fatigue.

Timeline

Start
2015-05-22
Primary completion
2017-06-20
Completion
2018-12-13

Drugs

EvaluationDrugModalityDoseRoute
Subject ACTH Unknown 40 iu Subcutaneous
Subject ACTH Unknown 80 iu Subcutaneous